Comprehensive Evaluation of Pathophysiology, Differential Diagnosis and Advanced Therapeutic Approaches in Rosacea: A Comprehensive Analysis
Main Article Content
Abstract
Rosacea, a chronic, recurrent skin disease, has long intrigued the medical community because of its complex pathophysiology and varied clinical presentation. In this article, a comprehensive assessment of current advances in understanding the underlying mechanisms of rosacea is presented. Inflammatory processes, neurovascular dysfunction, and possible genetic factors contributing to the development and progression of this condition are explored in detail.
In addition, the differential diagnosis of rosacea is discussed in depth, considering its clinical similarities with other dermatologic and vascular diseases, and the most recent diagnostic tools, such as dermoscopy and molecular tests, which have revolutionized diagnostic accuracy, are highlighted.
In terms of therapeutic approaches, conventional options such as topical and systemic agents are reviewed, as well as emerging therapies based on modulation of the skin microbiota and inhibition of specific inflammatory mediators. The efficacy and safety of laser therapies and minimally invasive procedures, which have shown promising results in the treatment of rosacea, are discussed.
This article offers a comprehensive overview of rosacea from an advanced medical perspective, highlighting advances in the understanding of its pathogenesis and providing a detailed guide to the diagnostic and treatment options currently available. The information presented is intended to inform and guide health care professionals in the optimal management of this complex clinical entity.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. J.Q. Del Rosso. Update on rosacea pathogenesis and correlation with medical therapeutic agents. Cutis, 78 (2006), pp. 97-100.
II. K.J. Butterwick, L.S. Butterwick, A. Han. Laser and light therapies for acne rosacea. J Drugs Dermatol, 5 (2006), pp. 35-39.
III. 3. H.E. Baldwin. Oral therapy for rosacea. J Drugs Dermatol, 5 (2006), pp. 16-21.
IV. B. Berman, D. Zell. Subantimicrobial dose doxycycline: a unique treatment for rosacea. Cutis, 75 (2005), pp. 19-24.
V. R.I. Ceilley. Advances in the topical treatment of acne and rosacea. J Drugs Dermatol, 3 (2004), pp. S12-22.
VI. R.H. Liu, M.K. Smith, S.A. Basta, E.R. Farmer. Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials. Arch Dermatol, 142 (2006), pp. 1047-1052 http://dx.doi.org/10.1001/archderm.142.8.1047
VII. S.A. Buechner. Rosacea: an update. Dermatology, 210 (2005), pp. 100-108
http://dx.doi.org/10.1159/000082564
VIII. S. Diamantis, H.A. Waldorf. Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol, 5 (2006), pp. 8-12.
IX. S. Laube, S.W. Lanigan. Laser treatment of rosacea.J Cosmet Dermatol, 1 (2002), pp. 188-195 http://dx.doi.org/10.1111/j.1473-2165.2002.00071.x
X. A.K. Gupta, M.M. Chaudhry. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol, 19 (2005), pp. 273-285 http://dx.doi.org/10.1111/j.1468-3083.2005.01216.x
XI. G.H. Crawford, M.T. Pelle, W.D. James. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol, 51 (2004),pp.327-341 http://dx.doi.org/10.1016/j.jaad.2004.03.030
XII. E.J. van Zuuren, A.K. Gupta, M.D. Gover, M. Graber, S. Hollis. Systematic review of rosacea treatments. J Am Acad Dermatol, 56 (2007), pp. 107-115 http://dx.doi.org/10.1016/j.jaad.2006.04.084
XIII. R. Odom. The nosology of rosacea. Cutis, 74 (2004), pp. 5-8.
XIV. J. Wilkin, M. Dahl, M. Detmar, L. Drake, A. Feinstein, R. Odom, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol, 46 (2002), pp. 584-587.
XV. National Rosacea Society. New survey pinpoints leading factors that trigger symptoms [online]. Summer 2002. Rosacea Review. Available at: http://www.rosacea.org/rr/2002/summer/article_3.php
XVI. J.K. Wilkin. Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol, 19 (1988), pp. 309-313.
XVII. G. Murphy. Ultraviolet light and rosacea. Cutis, 74 (2004), pp. 13-16.
XVIII. A.R. Amin, M.G. Attur, G.D. Thakker, P.D. Patel, P.R. Vyas, R.N. Patel, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A, 93 (1996), pp. 14014-14019.